India’s Pirtobrutinib 200mg Dose Tablets

So, Pirtobrutinib is this oral med thingy that’s made to stop something called Bruton’s Tyrosine Kinase (BTK) from doing its thing. And it’s this non-covalent inhibitor that people use for mantle cell lymphoma and CLL. The drug works by hitting the BTK signaling pathway – super important for those cancer cells to survive and spread.

There are two tablet strengths – 50 mg and 100 mg, by the way. The recommended dose for patients is 200 mg taken once daily, with the tablets packed in bottles containing 60 doses each. The dose you get is usually decided by how you’re doing and what the doc says.

Oncologists usually figure that out.